AstraZeneca Pauses Coronavirus Vaccine Trial, Rollout Doubts Dent Shares
1 sourceUpdated Sep 9, 2020
AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares on Wednesday as the move was seen as dimming prospects…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup